OBJECTIVES: Expression of anti-Saccharomyces cerevisiae antibodies (ASCA) identifies patients and individuals at risk for Crohn's disease and has also been reported in 40-60% of celiac disease (CD) cases, suggesting a role of host response to enteric microbiota in the development of inflammatory lesions. In this prospective study in patients with suspicion of CD, we evaluate the frequency and association of ASCA to serological responses for other host microbial targets formally associated with Crohn's disease, including the Pseudomonas fluorescens associated sequence I2 and a Bacteroides caccae TonB-linked outer membrane protein, OmpW. METHODS: Small bowel mucosal biopsies were taken from 242 patients with suspicion of CD, their sera were tested for antibodies to tissue transglutaminase (tTG), ASCA, I2, and OmpW. Eighty adult healthy blood donors were used as controls. RESULTS: The diagnosis of CD was confirmed on biopsy in 134 cases. The occurrence of ASCA and I2 positivity was significantly higher in adult CD patients than in patients with non-CD disease. Anti-I2 levels in the sera were significantly higher in adult CD patients than in non-CD disease or the controls and anti-OmpW levels in CD and non-CD patients when compared to controls. Positive seroreactivity to OmpW seemed to increase with age. Of the CD patients, 90% were seropositive for at least one microbial antigen tested. CONCLUSIONS: This study demonstrates a mosaic of disease-related serological responses to microbial antigens in patients with CD. Immune responses to commensal enteric bacteria may play a role in the small intestine mucosal damage in CD.
OBJECTIVES: Expression of anti-Saccharomyces cerevisiae antibodies (ASCA) identifies patients and individuals at risk for Crohn's disease and has also been reported in 40-60% of celiac disease (CD) cases, suggesting a role of host response to enteric microbiota in the development of inflammatory lesions. In this prospective study in patients with suspicion of CD, we evaluate the frequency and association of ASCA to serological responses for other host microbial targets formally associated with Crohn's disease, including the Pseudomonas fluorescens associated sequence I2 and a Bacteroides caccae TonB-linked outer membrane protein, OmpW. METHODS: Small bowel mucosal biopsies were taken from 242 patients with suspicion of CD, their sera were tested for antibodies to tissue transglutaminase (tTG), ASCA, I2, and OmpW. Eighty adult healthy blood donors were used as controls. RESULTS: The diagnosis of CD was confirmed on biopsy in 134 cases. The occurrence of ASCA and I2 positivity was significantly higher in adult CDpatients than in patients with non-CD disease. Anti-I2 levels in the sera were significantly higher in adult CDpatients than in non-CD disease or the controls and anti-OmpW levels in CD and non-CDpatients when compared to controls. Positive seroreactivity to OmpW seemed to increase with age. Of the CDpatients, 90% were seropositive for at least one microbial antigen tested. CONCLUSIONS: This study demonstrates a mosaic of disease-related serological responses to microbial antigens in patients with CD. Immune responses to commensal enteric bacteria may play a role in the small intestine mucosal damage in CD.
Authors: Sandro Drago; Ramzi El Asmar; Mariarosaria Di Pierro; Maria Grazia Clemente; Amit Tripathi; Anna Sapone; Manjusha Thakar; Giuseppe Iacono; Antonio Carroccio; Cinzia D'Agate; Tarcisio Not; Lucia Zampini; Carlo Catassi; Alessio Fasano Journal: Scand J Gastroenterol Date: 2006-04 Impact factor: 2.423
Authors: A García-Lafuente; M Antolín; F Guarner; E Crespo; A Salas; P Forcada; M Laguarda; J Gavaldá; J A Baena; J Vilaseca; J R Malagelada Journal: Am J Physiol Date: 1997-01
Authors: M Peeters; B Geypens; D Claus; H Nevens; Y Ghoos; G Verbeke; F Baert; S Vermeire; R Vlietinck; P Rutgeerts Journal: Gastroenterology Date: 1997-09 Impact factor: 22.682
Authors: Jan G M C Damoiseaux; Bas Bouten; Annick M L W Linders; Jos Austen; Caroline Roozendaal; Maurice G V M Russel; Pierre-Philippe Forget; Jan Willem Cohen Tervaert Journal: J Clin Immunol Date: 2002-09 Impact factor: 8.317
Authors: Marla C Dubinsky; Ying-Chao Lin; Debra Dutridge; Yoana Picornell; Carol J Landers; Sharmayne Farrior; Iwona Wrobel; Antonio Quiros; Eric A Vasiliauskas; Bruce Grill; David Israel; Ron Bahar; Dennis Christie; Ghassan Wahbeh; Gary Silber; Saied Dallazadeh; Praful Shah; Danny Thomas; Drew Kelts; Robert M Hershberg; Charles O Elson; Stephan R Targan; Kent D Taylor; Jerome I Rotter; Huiying Yang Journal: Am J Gastroenterol Date: 2006-02 Impact factor: 10.864
Authors: S Desplat-Jégo; C Johanet; A Escande; J Goetz; N Fabien; N Olsson; E Ballot; J Sarles; J J Baudon; J C Grimaud; M Veyrac; P Chamouard; R L Humbel Journal: World J Gastroenterol Date: 2007-04-28 Impact factor: 5.742
Authors: M G Clemente; S De Virgiliis; J S Kang; R Macatagney; M P Musu; M R Di Pierro; S Drago; M Congia; A Fasano Journal: Gut Date: 2003-02 Impact factor: 23.059
Authors: Manuel A Silva; Jennifer Jury; Yolanda Sanz; Michelle Wiepjes; Xianxi Huang; Joseph A Murray; Chella S David; Alessio Fasano; Elena F Verdú Journal: Dig Dis Sci Date: 2011-08-07 Impact factor: 3.199
Authors: Tyson R Chiaro; Ray Soto; W Zac Stephens; Jason L Kubinak; Charisse Petersen; Lasha Gogokhia; Rickesha Bell; Julio C Delgado; James Cox; Warren Voth; Jessica Brown; David J Stillman; Ryan M O'Connell; Anne E Tebo; June L Round Journal: Sci Transl Med Date: 2017-03-08 Impact factor: 17.956
Authors: Sara Ashorn; Tuuli Välineva; Katri Kaukinen; Merja Ashorn; Jonathan Braun; Hanna Raukola; Immo Rantala; Pekka Collin; Markku Mäki; Tiina Luukkaala; Sari Iltanen Journal: J Clin Immunol Date: 2008-11-06 Impact factor: 8.317
Authors: Liisa Viitasalo; Laura Niemi; Merja Ashorn; Sara Ashorn; Jonathan Braun; Heini Huhtala; Pekka Collin; Markku Mäki; Katri Kaukinen; Kalle Kurppa; Sari Iltanen Journal: J Clin Gastroenterol Date: 2014-08 Impact factor: 3.062
Authors: Jane M Natividad; Xianxi Huang; Emma Slack; Jennifer Jury; Yolanda Sanz; Chella David; Emmanuel Denou; Pinchang Yang; Joseph Murray; Kathy D McCoy; Elena F Verdú Journal: PLoS One Date: 2009-07-31 Impact factor: 3.240